Health-related quality of life (HRQoL) in KEYNOTE-604: Pembrolizumab (pembro) or placebo added to etoposide and platinum (EP) as first-line therapy for ES-SCLC Meeting Abstract
| Authors: | Kim, H. R.; Awad, M. M.; Navarro, A.; Gottfried, M.; Peters, S.; Csoszi, T.; Cheema, P. K.; Rodriguez-Abreu, D.; Wollner, M.; Yang, J. C. H.; Mazieres, J.; Orlandi, F. J.; Luft, A.; Gumus, M.; Kato, T.; Kalemkerian, G. P.; Luo, Y.; Santorelli, M. L.; Pietanza, M. C.; Rudin, C. M. |
| Abstract Title: | Health-related quality of life (HRQoL) in KEYNOTE-604: Pembrolizumab (pembro) or placebo added to etoposide and platinum (EP) as first-line therapy for ES-SCLC |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S1033 |
| End Page: | S1034 |
| Language: | English |
| ACCESSION: | WOS:000573469102367 |
| DOI: | 10.1016/j.annonc.2020.08.1544 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1782MO -- Source: Wos |
